
Monisha Prabhu Macedo
About Monisha Prabhu Macedo
Data last updated:
Monisha Prabhu Macedo is a Nominee Director at Sterling Biotech Limited (since 2025), Director at Interise Investment Managers Private Limited (since 2018) and Director at Interise Investment Managers Private Limited (since 2018), and holds 3 more current directorships. The companies operate in Pharma, Financial Services and Consumer Electronics & Durables. The 5 current companies with reported revenue have a combined latest revenue of ₹873 Cr; the largest is Sterling Biotech Limited at ₹767 Cr (FY 2025). Earlier, Monisha Prabhu Macedo was a Whole-Time Director at Noida Toll Bridge Company Limited (1998–2017) and Director at Itnl Toll Management Services Limited (2007–2017) and 4 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Nominee Director | 24 Mar 2025 | 1985 | ₹767 Cr (FY 2025) | Active | |
| Director | 28 Jun 2018 | 1999 | ₹53.09 Cr (FY 2025) | Active | |
| Director | 28 Jun 2018 | 1999 | ₹53.09 Cr (FY 2025) | Active | |
| Director | 31 May 1990 | 1921 | ₹1.8 Lakh (FY 2025) | Active | |
| Director | 04 Sep 2009 | 2005 | ₹12,153 (FY 2024) | Under Process Of Striking Off | |
| Designated Partner | 30 Sep 2021 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 11 Dec 1998 | 1996 | ₹42.61 Cr (FY 2025) | Active | |
| Director | 22 Jun 2007 | 2007 | ₹2.55 Cr (FY 2025) | Active | |
| Designated Partner | 18 Oct 2018 | 2018 | Active | ||
| Director | 21 Mar 2007 | 2004 | Amalgamated | ||
| Director | 22 Jan 2008 | 2008 | Amalgamated | ||
| Director | 20 Jun 2006 | 1995 | ₹18.1 Lakh (FY 2026) | Under Liquidation |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Monisha Prabhu Macedo
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Monisha Prabhu Macedo
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Monisha Prabhu Macedo
Monisha Prabhu Macedo currently holds 6 directorships: Sterling Biotech Limited (Nominee Director, since 24 Mar 2025, revenue ₹767 Cr (FY 2025)); Interise Investment Managers Private Limited (Director, since 28 Jun 2018, revenue ₹53.09 Cr (FY 2025)); Interise Investment Managers Private Limited (Director, since 28 Jun 2018, revenue ₹53.09 Cr (FY 2025)); Dyers Stone Lime Company Private Limited (Director, since 31 May 1990, revenue ₹1.8 Lakh (FY 2025)); Monisha Macedo Consultants Private Limited (Director, since 04 Sep 2009, revenue ₹12,153 (FY 2024)); and 1 more.
Monisha Prabhu Macedo was first appointed on 31 May 1990 as Director at Dyers Stone Lime Company Private Limited. The most recent appointment on record is 24 Mar 2025 at Sterling Biotech Limited.
The 5 current companies of Monisha Prabhu Macedo that report revenue have a combined latest revenue of ₹873 Cr: Sterling Biotech Limited ₹767 Cr (FY 2025); Interise Investment Managers Private Limited ₹53.09 Cr (FY 2025); Interise Investment Managers Private Limited ₹53.09 Cr (FY 2025); Dyers Stone Lime Company Private Limited ₹1.8 Lakh (FY 2025); Monisha Macedo Consultants Private Limited ₹12,153 (FY 2024).
Monisha Prabhu Macedo held 6 earlier board appointments: Noida Toll Bridge Company Limited (Whole-Time Director, 11 Dec 1998 to 14 Mar 2017); Itnl Toll Management Services Limited (Director, 22 Jun 2007 to 05 Apr 2017); Sankhya Ventures Llp (Designated Partner, 18 Oct 2018 to 30 Aug 2019); Dnd Flyway Limited (Director, from 21 Mar 2007); Il&Fs Urban Infrastructure Services Limited (Director, from 22 Jan 2008); and 1 more.
The current boards of Monisha Prabhu Macedo's companies include Aftab Mathur (Sterling Biotech Limited), Alok Kumar Garg (Sterling Biotech Limited), Anil Shantilal Inani (Sterling Biotech Limited), Keyur Anilkumar Parekh (Sterling Biotech Limited), Neha Champaben Prajapati (Sterling Biotech Limited), Priyadarshan Kumar Singh (Sterling Biotech Limited), among others.